Article Details
Retrieved on: 2021-05-05 18:45:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The four anti-CGRP monoclonal antibodies are all prophylactic agents. Galcanezumab, fremanezumab, and eptinezumab prevent migraines by directly ...
Article found on: www.practicalpainmanagement.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here